AKORN FDA Approval ANDA 207049

ANDA 207049

AKORN

FDA Drug Application

Application #207049

Application Sponsors

ANDA 207049AKORN

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL50MG0VORICONAZOLEVORICONAZOLE
002TABLET;ORAL200MG0VORICONAZOLEVORICONAZOLE

FDA Submissions

UNKNOWN; ORIG1AP2016-09-07STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

AKORN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 207049
            [companyName] => AKORN
            [docInserts] => ["",""]
            [products] => [{"drugName":"VORICONAZOLE","activeIngredients":"VORICONAZOLE","strength":"50MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"VORICONAZOLE","activeIngredients":"VORICONAZOLE","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/07\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2016-09-07
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.